INNOVATE Ocular Oncology continues in the tradition of our INNOVATE series where scientific, clinical and industry leaders come together to educate and inform participants on the state-of-the-art and future trends in ocular oncology. This is a critical time in this field- even with the approval of new therapies, increased clinical trial options, and advanced diagnostics there are still unmet needs in terms of treatment burden, toxicities, and access to care. INNOVATE Ocular Oncology aims to address these issues head on with provocative lectures, cutting edge research presentations, and panel discussions with leaders in biopharma. The hallmark of this meeting rests with hard questions, lively discussion, and a collegial inter-disciplinary environment.
Please note this meeting will not offer continuing medical education (CME) credits.
Ocular oncologists, ophthalmologists, medical oncologists, ocular pathologists, radiation oncologists, pediatric oncologists, anterior segment and retina specialists, biopharma representatives, translational scientists, patients and patient advocates.
This activity is supported by The Alan and Irene Adler Ocular Cancer Research Initiative.